Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,806 | -28,246 | -19,494 | -6,529 | -23,445 |
| Depreciation Amortization | 110 | 81 | 55 | 28 | 110 |
| Accounts receivable | -158 | 105 | 19 | 102 | 90 |
| Other Working Capital | 1,947 | 3,021 | 3,011 | 1,433 | -1,239 |
| Other Operating Activity | 9,491 | 7,007 | 4,893 | 1,024 | 7,501 |
| Operating Cash Flow | $-25,416 | $-18,032 | $-11,515 | $-3,943 | $-16,983 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -35,015 | -35,015 | -35,004 | N/A | -22,011 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 274 |
| Investing Cash Flow | $-35,015 | $-35,015 | $-35,004 | $N/A | $-21,737 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -3,888 |
| Common Stock Issued | 151,187 | 151,187 | 150,931 | 154 | 49,248 |
| Common Stock Repurchased | 133 | 89 | 27 | 27 | 81 |
| Other Financing Activity | -9,330 | -9,299 | -9,170 | -30 | -3,664 |
| Financing Cash Flow | $141,991 | $141,977 | $141,788 | $151 | $41,777 |
| Exchange Rate Effect | -56 | -57 | -28 | -45 | -58 |
| Beginning Cash Position | 56,321 | 56,321 | 56,321 | 56,321 | 53,323 |
| End Cash Position | 137,825 | 145,194 | 151,562 | 52,485 | 56,321 |
| Net Cash Flow | $81,504 | $88,873 | $95,242 | $-3,836 | $2,998 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,416 | -18,032 | -11,515 | -3,943 | -16,983 |
| Free Cash Flow | -25,416 | -18,032 | -11,515 | -3,943 | -16,983 |